Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, July 7th:
Verona Pharma VRNA: This company which is focused on developing and commercializing innovative therapeutics for the treatment of patients burdened with chronic respiratory diseases with significant unmet medical needs, has a Zacks Rank #1(Strong Buy), and witnessed the Zacks Consensus Estimate for its current year earnings increasing 37.5% over the last 60 days.
Verona Pharma PLC American Depositary Share Price and Consensus
Verona Pharma PLC American Depositary Share price-consensus-chart | Verona Pharma PLC American Depositary Share Quote
Verona Pharma’s shares gained 69% over the last three month compared with the S&P 500’s gain of 26%. The company possesses a Momentum Score of A.
Verona Pharma PLC American Depositary Share Price
Verona Pharma PLC American Depositary Share price | Verona Pharma PLC American Depositary Share Quote
Evolv Technologies EVLV: This company which offer an array of AI touchless screening technologies for weapons detection, identity verification and health-related threats through Evolv Cortex AI(TM) software platform, has a Zacks Rank #1, and witnessed the Zacks Consensus Estimate for its current year earnings increasing 23.3% over the last 60 days.
Evolv Technologies Holdings, Inc. Price and Consensus
Evolv Technologies Holdings, Inc. price-consensus-chart | Evolv Technologies Holdings, Inc. Quote
Evolv Technologies’ shares gained 100.7% over the last three month compared with the S&P 500’s gain of 25.9%. The company possesses a Momentum Score of B.
Evolv Technologies Holdings, Inc. Price
Evolv Technologies Holdings, Inc. price | Evolv Technologies Holdings, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Only $1 to See All Zacks’ Buys and Sells
We’re not kidding.
Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent. Thousands have taken advantage of this opportunity.
Thousands did not – they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators, and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.
Evolv Technologies Holdings, Inc. (EVLV) : Free Stock Analysis Report
Verona Pharma PLC American Depositary Share (VRNA) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).